Tocqueville Asset Management L.P. Alkermes Plc. Transaction History

Tocqueville Asset Management L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$27.94 - $44.61 $754,771 - $1.21 Million	-27,014 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$38.6 - $46.12 $19,300 - $23,060	-500 Reduced 1.82%	27,014 $1.15 Million
Q2 2018 Aug 13, 2018	SELL	$40.56 - $51.36 $597,894 - $757,097	-14,741 Reduced 34.89%	27,514 $1.13 Million
Q4 2017 Feb 13, 2018	SELL	$47.69 - $55.39 $15.4 Million - $17.9 Million	-322,586 Reduced 88.42%	42,255 $2.31 Million
Q3 2017 Oct 30, 2017	BUY	$49.16 - $54.45 $17.9 Million - $19.9 Million	364,841	364,841 $18.5 Million

376

173M

231K

158K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.63B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.